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Abstract
Implantation of the embryo in the uterus is a critical and complex event and its failure is widely
considered an impediment to improved success in assisted reproduction. Depending on whether
placentation is invasive or superficial (epitheliochorial), the embryo may interact transiently or
undergo a prolonged adhesive interaction with the uterine epithelium. Numerous candidate
interactions have been identified, and there is good progress on identifying gene networks required
for early placentation. However no molecular mechanisms for the epithelial phase are yet firmly
established in any species. It is noteworthy that gene ablation in mice has so far failed to identify
obligatory initial molecular events.
Milestones of implantation
Implantation of the embryo into the uterine wall is a
requirement for developmental progression beyond the
blastocyst stage in vivo. Its obvious significance to species
survival implies the need for a robust mechanism that can
survive suboptimal conditions of e.g. nutrition or infec-
tion. Since problems in pregnancy frequently originate in
the pre and peri-implantation period, understanding the
mechanisms of implantation will facilitate the discovery
of therapies applicable at a time when both embryo and
endometrium are at their most accessible.
The human embryo implants about 7–11 days after the
LH peak [1,2]. Many human conceptuses fail to implant
because of genetic or metabolic abnormalities [3,4], but
poor uterine receptivity has been widely proposed as
another cause of implantation failure [5-8]. In rat and
mouse, the implantation window lasts for only about 24
h at day 4–5 of pregnancy [9]. Unimplanted blastocysts
recovered by flushing and transferred to receptive mothers
give normal pregnancies, and blastocysts transferred to
pre-receptive uteri implant according to the maternal
schedule [10,11], indicating that receptivity is largely
maternally controlled. However, the molecular basis of
this phenomenon is not understood. In domestic live-
stock species with non-invasive (epitheliochorial or syne-
pitheliochorial) implantation, a pre-attachment phase of
8–15 days is followed by a more prolonged period of
apposition and attachment; as a result, these species offer
clear advantages for the elucidation of cell adhesion and
intercellular communication mechanisms.
Hormonal requirements for implantation have been
defined by replacing embryos in ovariectomised mice or
rats under various regimes of exogenous steroid. The
required sequence is estrogen (E) followed by progester-
one (P), and then E plus P. The E/P-primed uterus sup-
ports the survival of blastocysts within the lumen for a
considerable time, as long as daily P is administered
(delayed implantation), and a dose of E during P stimula-
tion is an absolute necessity for implantation to occur.
This corresponds to the nidatory E pulse in natural cycles.
Experimentally, the size of the E dose affects the duration
of the receptive phase [8]. The post-receptive uterus is
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hostile to unimplanted embryos, which degenerate. While
rats and mice are useful model systems, some key features
are clearly not relevant to human where, for example, the
influence of a post-implantation uterine cavity on unim-
planted conceptuses is irrelevant since menstruation is
imminent [12]. The human receptive phase probably ends
when corpus luteum rescue is no longer feasible.
Pre-implantation endocrine patterns during human con-
ception cycles resemble closely those seen in non-concep-
tion cycles, though circulating luteal phase E and P levels
are rather higher in the former [13]. Endometrial prepara-
tion in artificial cycles does not depend on the precise rep-
lication of natural cycles [6], and it remains unclear
whether luteal phase E production is required for implan-
tation in women. The high level of E in ovarian hyperstim-
ulation cycles has an adverse effect on mouse endometrial
receptivity [8], but may also affect the embryo directly
with inhibition of implantation, as observed in vitro [14].
If mouse embryos are transferred to one oviduct at the
pronuclear stage, and simultaneously into the contralat-
eral oviduct at the 8 cell stage, both implant, though in the
former case implantation is delayed by at least one day.
Developmental synchronisation has occurred by the neu-
ral plate stage [15]. This experiment suggests that an
embryo-maternal dialogue influences the timing of the
receptive phase.
Gland cell secretions and the early embryo-
maternal dialogue
The early human maternal-fetal interface is characterised
by the blockage (by trophoblast) of maternal spiral arter-
ies and no blood flow through the intervillous space, so
the system is very hypoxic. In contrast to the arteries,
maternal glands open into the intervillous space, and gly-
cogen and other glandular secretory substances (histio-
troph) are taken up by trophoblast [16]. In the mouse,
ablation of the hypoxia inducible gene Arnt/HIF1α leads
to abnormal placental development and pregnancy fail-
ure, suggesting a role for hypoxia-regulated genes. In
sheep lacking uterine glands, embryos develop to the
hatched blastocyst stage, but do not progress, probably
because of a failure of attachment [17]. This suggests that
glandular histiotroph may contribute to implantation
[18].
Calcitonin is an endometrial gland cell secretory product
expressed in response to P [19] that is important for preg-
nancy outcome in rats, as indicated by a reduction in
implantation rates if maternal expression is blocked using
antisense oligonucleotide [20]. Calcitonin acts on the pre-
implantation embryo by binding a G-protein-coupled
receptor, triggering an increase in intracellular calcium,
activation of adenyl cyclase and expression of the
fibronectin receptor, integrin α5β1 [21], a part of the acti-
vation step (see below).
Mouse uterine glands secrete leukaemia inhibitory factor
(LIF) which is essential for implantation [22]. It binds to
receptors in the luminal epithelium (LE), triggering stat-3
activation only on the day of implantation [23]. Together
with embryo-derived signals, LIF, acting via the LE initi-
ates a signalling cascade that leads to stromal decidualisa-
tion [24]. However LIF inhibits decidualisation of stromal
cells in vitro perhaps suggesting a restraining role away
from the implantation site [25]. Various molecular abnor-
malities are associated with the absence of LIFduring the
receptive phase, such as lack of expression of Cox-2 and
EGF family cytokines including heparin-binding epider-
mal growth factor (HB-EGF [26]) as well as the secreted
protein coch-5b2 [27]. The prostaglandins/prostacyclins,
products of Cox enzyme activity, have been considered
important instruments in initiating decidualisation.
Indeed when wild type embryos were transferred to the
uteri of Cox-2 null C57Bl/6J/129 mice a decidualisation
reaction was not observed and they were reported not to
implant [28,29]. However in another study on these mice
it was shown that implantation occurs normally but
decidualisation is delayed [30]. Moreover it appears that,
in Cox-2 null CD-1 mice, compensatory upregulation of
Cox-1 occurs at the implantation site, maintaining prosta-
cyclin levels and allowing at least some implantation reac-
tion although this is delayed [29]. These observations
make evident the importance of genetic background [31].
It is clear that the embryo signals its presence to the mater-
nal system but few changes in decidualising stroma have
been identified solely in response to the embryo, as dis-
tinct from being products of decidual differentiation.
Although interferonτ (an important embryonic signal to
the mother in ruminants) is not produced by murine blas-
tocysts, an interferon–stimulated gene (Isg15) has
recently been shown to be expressed in murine decidua, as
in other species, in an embryo-dependent manner [32].
Embryo growth, hatching and activation
Metabolic changes occur during pre-implantation devel-
opment, from the relative quiescence of the cleavage
stages to the metabolically more active blastocyst with its
high rate of glucose uptake [33]. Replacement of blasto-
cysts has been advocated in human assisted reproduction
programs, since it allows preimplantation genetic investi-
gation to be carried out after removal of one or two cells
at the cleavage stages [34,3]. A two-stage culture protocol
has been adopted with somewhat richer nutrient provi-
sion during the morula to blastocyst phase [35]. When
culture is carried out continuously in nutrient-poor
medium, some embryos develop to blastocysts, but
implantation rates are reduced. Human blastocystReproductive Biology and Endocrinology 2004, 2:48 http://www.rbej.com/content/2/1/48
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morphology varies greatly, but karyotypically abnormal
embryos can develop into apparently normal blastocysts.
Just as with the karyotype, the metabolic characteristics of
morphologically normal blastocysts vary greatly [36].
Thus the ability of an embryo to develop to this stage does
not guarantee successful pregnancy. However, morphol-
ogy of karyotypically normal blastocysts is likely to be a
good indicator of pregnancy outcome [37]. Blastocyst, as
opposed to early cleavage, transfer allows synchrony
between embryo and tract environment, and allows selec-
tion of competent embryos to facilitate single embryo
transfer.
Growth factors secreted in response to E and P from both
oviductal and endometrial epithelium contribute to the
milieu of the developing embryo. Numerous factors,
including insulin, LIF, leptin, heparin-binding epidermal
growth factor (HB-EGF) granulocyte-macrophage colony
stimulating factor (GM-CSF) and insulin like growth fac-
tor 1 (IGF-1) have been shown to increase either the rate
of embryo development to blastocyst stage or blastocyst
cell number in culture (Figure; reviewed in: [38,39]. Stud-
ies in genetically modified mice have also demonstrated a
clear role for pre-implantation signalling between mother
and embryo. GM-CSF is produced by the uterine epithe-
lium and stimulated by E [40] while the embryo expresses
a GM-CSF receptor [41]. Mice genetically altered to lack
GM-CSF produce blastocysts with fewer cells in the ICM,
and these give rise to small pups. The defect can be res-
cued by culturing null preimplantation embryos in
medium supplemented with GM-CSF before replacement
[41]. In cow, GM-CSF localises to the apical LE surface
both before and after embryo attachment, and is upregu-
lated by interferon-τ produced by the embryo [42].
Human embryos express GM-CSF receptors [43,44] and
so can respond to this ligand.
Before an embryo can attach to the uterine surface, it must
hatch from the zona pellucida. Two serine proteases, ISP1
and ISP2 (implantation serine proteases 1 and 2), have
been implicated in hatching. ISP1 is produced by the
embryo, while ISP2 is produced by uterine glands. These
enzymes may also be required for local proteolysis of
maternal tissue as part of the process of invasion [45].
In addition to metabolic activation and hatching, the
blastocyst must be activated to attach to maternal luminal
epithelium (LE), at least in the mouse model of delayed
implantation. In the presence of P, dormant blastocysts
are closely apposed to the uterine epithelium but do not
attach. E treatment produces a receptive state in the uterus
mediated by interaction of estradiol-17β with its nuclear
receptor. In contrast, the embryo is activated (as evi-
denced by induced EGF binding) by a catecholestrogen, 4-
hydroxyestradiol-17β, produced locally in the
endometrium as a metabolite of estradiol [46-48]. Activa-
tion of blastocysts is unaffected by blocking nuclear ER
signalling, but prevented by inhibition of prostaglandin
(PG) synthesis, adenyl cyclase or protein kinase A (PKA).
This suggests a pathway in which PG stimulates cAMP syn-
thesis to mediate activation though PKA. One important
manifestation of activation is the early translocation of
integrins α5β1 and α4β1 to the apical surface of abembry-
onic TE in mice [49,21,50]. Integrin α5β1-fibronectin
engagement induces calmodulin-mediated calcium tran-
sients in the blastocyst, suggesting outside-in signalling
[51]. Moreover, fibronectin induces trafficking of αIIbβ3
and appears to be involved in the strengthening of inter-
action between trophoblast and uterine fibronectin as tro-
phoblast invasion commences [52].
After attachment to the epithelial surface, embryos of
interstitially implanting species invade the underlying
stroma. Embryonic genes are emerging which have essen-
tial functions in the early post-epithelial phases of
implantation; their ablation gives a phenotype that resem-
bles implantation failure. Mouse embryos genetically
modified to lack integrin β1 fail to complete implanta-
tion, probably because of an inability to bind the mater-
nal subepithelial extracellular matrix [53]. Embryos
lacking the Ron/STK receptor tyrosine kinase, a member
of the c-met family which is expressed in trophoblast, fail
at similarly early stages. Its ligand HGFL is contemporane-
ously expressed in the uterus. However, HGFL-null ani-
mals implant normally, suggesting the existence of
another ligand [54]. Others have reviewed genes required
for early development of the embryo/placenta [55,56].
Hormonal influences on the endometrium at 
implantation
The classical model of E acting on endometrial cells to
stimulate P receptor expression, with P then inducing dif-
ferentiation and preparation for implantation, is an over-
simplification, because receptor expression varies in a
complex fashion in different cell types and tissue com-
partments in the uterus [57]. The basal endometrium,
from which post-menstrual regeneration occurs in
human, differs from the superficial or functional layer
[58]. These differences arise at least in part because of site-
specific paracrine interactions between the epithelium
and stroma in regulating endometrial function, as estab-
lished elegantly in studies of mice lacking E receptors [59].
Epithelial proliferation in response to E does not occur in
receptor (ERα)-negative stroma recombined with wild
type epithelium, but occurs normally if the receptor is
present in the stroma and not the epithelium. However,
the control of expression of epithelial secretory proteins
such as mouse lactoferrin relies on the presence of recep-
tor in both stromal and epithelial compartments. The
same principles apply to human endometrium; forReproductive Biology and Endocrinology 2004, 2:48 http://www.rbej.com/content/2/1/48
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example, in secretory phase, P stimulates PR-bearing stro-
mal cells to produce transforming growth factor β (TGFβ),
and this in turn suppresses production of matrix metallo-
proteinase 7 (MMP7) by the epithelium in a P-independ-
ent step. At the end of the cycle, P levels fall and MMP7
contributes to extracellular matrix (ECM) remodelling
during menstruation [60-62].
Although ERα is thought to be the main receptor mediat-
ing E effects in the uterus, both mouse and human
endometrium express lower levels of ERβ. Ablation of ERβ
in mice compromises reproductive function [63] and cur-
rent evidence suggests it may act to modulate ERα. Simi-
larly, P receptor splice variants A and B function as distinct
transcription factors [64]. The localisation of ERβ (but not
PR) to uterine NK cells [65] which colonise the
endometrium in late secretory phase, serves to emphasise
that careful delineation of the cell types in which receptors
are expressed is just as important as monitoring their cycle
dependency.
Endocrine mediators other than E and P also play a role.
Endometrial cells express the androgen receptor AR [66]),
the luteinising hormone receptor LHR[67], the gonado-
trophin-releasing hormone receptor [68], the prolactin
receptor [69], the leptin receptor Ob-R [70] and the
relaxin receptors LGR 7 and 8 [71]. AR can be expressed in
stromal as well as epithelial cells but its functions in
endometrial physiology have not been defined. Human
chorionic gonadotrophin (hCG) is a ligand for LHR, rais-
ing the possibility of a paracrine interaction with the
embryo. Mice genetically altered to lack LHR develop a
very small uterus [72]. After steroid replacement, the
uterus returns to a normal size and histological features
are fairly normal, though fewer glands are present.
Embryos transferred into these mice however produce no
pregnancies, and at present the explanation for this infer-
tility is not clear. There is evidence that hCG may advance
endometrial differentation [73] and act as an autocrine
regulator of trophoblast [74]. Parathyroid-related hor-
mone produced by endometrium induces primary and
secondary mouse trophoblast differentation to giant cells
in vitro [75] El-Hashash and Kimber unpublished. Prolac-
tin, produced by human stromal cells undergoing decidu-
alisation, activates receptors on uterine large granulated
lymphocytes [69] potentially influencing their role in
post-implantation uterine function.
The endometrial transcriptome
Recently, the search for elusive markers of endometrial
receptivity has included differential display, subtractive
hybridisation and differential microarray screening to
compare the endometrial transcriptome in receptive and
non-receptive states. It is conceptually useful in these
studies to distinguish genes (such as tyrosine kinase fam-
ily receptors or transcription factors) that may directly or
indirectly influence the downstream expression of a set of
target genes from those (such as integrins) directly
involved in cell interactions. Since implantation seems to
occur in a range of endometrial 'settings' (i.e. variations in
gene expression), it will be necessary to ask whether
expression of 'master genes' with the ability to change
these settings is altered in infertile women.
Several studies [76-79] have compared human mid secre-
tory phase endometrium with non-receptive stages (either
early secretory or proliferative). In one study, patient-to-
patient variation was eliminated by sampling tissue from
the same individual at two different times of the same
cycle [79]. Consistent patterns of 'receptive state' gene
expression have not yet emerged. Some known genes –
osteopontin is a notable example [80] – exhibit altera-
tions consistent with previous data (see below). New
genes will require functional study, for example IGFBP-
rP1/mac 25 [81]. Certain genes are conspicuous by their
absence (indicating lack of detected up or down regula-
tion): notably the transcription factor HoxA10 and the
growth factor LIF, both essential for implantation in
mouse as revealed by gene ablation, and integrin β3, a
subunit of the epithelial and vascular receptor αvβ3 which
is regulated by Hoxa10 [82] and a candidate for mediating
embryo attachment to the uterine epithelium (see below).
Animal models can offer better-controlled approaches.
Reese and colleagues [83] identified mouse genes expres-
sion of which is altered in both  implantation vs inter-
implantation site and delayed implantation uterus (P
only) vs tissue that had been E-treated to terminate the
delay. Distinct sets of genes are upregulated or repressed
in inter-site tissue vs the implantation site, with numerous
functional categories represented. Nearly half the genes
repressed by E or at implantation sites have immune–
related functions. Connexins 26 and 43 and amphiregulin
are notably elevated in implantation-receptive RNA iso-
lates, as is nexin-1, a serine protease inhibitor expressed in
uterine stromal cells [84]. Decysin, a member of the
ADAM family that is present in the uterine stroma, is
down-regulated at the implantation site and shows
altered expression in the prolactin receptor-null mouse,
which exhibits implantation failure that is partially over-
come by exogenous P treatment [85]. In a study compar-
ing luminal epithelial genes from implantation site and
interimplantation site there was notable upregulation of
genes involved with the extracellular matrix and its
remodeling or associated with calcium for function at the
implantation site [86].
Differential display of cDNA species present in implanta-
tion and inter-implantation sites on day 4.5 of pregnancy
in the mouse has identified differential expression ofReproductive Biology and Endocrinology 2004, 2:48 http://www.rbej.com/content/2/1/48
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several proteins. This includes an increase in transcripts
encoding the calcium binding protein calbindin-d9k
(CABP-d9k) in the luminal epithelium at the interimplan-
tation site [87,88]. Downregulation of CABP-d9k at the
implantation site [89] or after blastocyst transfer [90] sug-
gests precise spatial and temporal regulation of calcium-
mediated signalling, or calcium availability, may be criti-
cal during implantation as also indicated by the impor-
tance of calcitonin (see above). Subtractive hybridisation
of endometrial libraries has identified other interesting
leads in rhesus monkey [91] and rabbit [92].
Mouse maternal implantation genes regulated by P have
been identified by transcriptomic analysis comparing
receptive phase uterus with or without an implantation-
blocking dose of the anti-progestin RU486. P-dependence
was subsequently confirmed by re-assay in the P receptor
knock-out (PRKO) mouse [93]. Alterations are observed
in several genes of known importance including Hoxa11
[94,95], amphiregulin [83,96], laminin α2 [97] and sper-
midine synthase [83], validating the approach. In vivo
uterine administration of antisense oligonucleotide to
Irg1, a gene identified in the implantation phase LE,
blocked implantation [93]. Other novel genes are now
candidates for functional analysis.
The cellular and molecular events of embryo 
attachment
In all species there is an initial interaction, no matter how
short-lived, between the outer TE cell surface and the api-
cal LE. It is likely that a cascade of adhesion events is ini-
tiated [98-100] (see Fig). In turn this leads to signalling
events, targets for which are located in both epithelial and
subjacent stromal cells. Other than the most immediate
responses at implantation, the stromal changes lie outside
the scope of this review.
A change in epithelial cell organisation at the time of
implantation seems to occur generally across the range of
mammals, irrespective of differences in control mecha-
nisms and subsequent trophoblast behaviour [101]. In
mice, attachment to the maternal epithelial surface is fol-
lowed by apoptosis of the epithelial cells, allowing tro-
phoblast direct access to the underlying basement
membrane and stroma [102,103]. In human, it is thought
that intrusive penetration of the epithelium is followed by
its displacement, but there is also evidence that epithelial
apoptosis may occur [104].
Epithelial junctions
Early postovulatory and receptive LE have very different
phenotypes. Gap junction distribution and complexity
changes in the LE lateral membrane in several species at
receptivity. Connexins 26 and 43 are regulated in LE and
stroma during the human menstrual cycle [105]. Con-
nexin 26 is expressed in the rodent implantation chamber
epithelium, and CX26 and 43 in stroma, and these are
tightly regulated by ovarian steroids including progester-
one-mediated suppression [106,107]. Alterations in LE
cell-cell interactions are also indicated by changes in the
apico-lateral distribution of cell surface molecules, for
instance integrin α6 distribution changes from basal to
both lateral and basal during the secretory phase [108]. In
mouse, E-induced E-cadherin degradation leads to
reduced LE adhesion on d4.5 of pregnancy [109]. Lateral
cadherins have also been reported to relocate to the apical
LE surface at the time of implantation in rat [110]. In
women, changes in E-cadherin mRNA probably reflect E-
dependent down regulation [111]. Desmosomal proteins
are downregulated and redistributed along the lateral cell
surfaces in murine LE [112] and the density of desmo-
somes similarly decreases in human at the expected time
of implantation [113]. LE cell polarity becomes less
marked with appearance of latero-basal markers in the
apical membrane [114]. The cells are flatter and microvilli
are replaced by bulbous protrusions (uterodomes) in
many species [115,116]. In women, uterodomes appear
in LE cells about 5–6 days after ovulation [117-119] cor-
relating with the expected receptive phase. Studies using
repeated biopsy demonstrated that uterodomes have a
lifetime of less than 48 h. Three human blastocysts co-cul-
tured with endometrial epithelial cells were reported to
attach where clusters of cells bearing uterodomes were
present in the cell layer [118].
Epithelial glycobiology and attachment
In common with other epithelial surfaces, the uterine LE
contains an apical glycocalyx which allows the diffusion
of small molecules but inhibits cell adhesion [99], and
protects the upper tract from infectious agents. The cell
surface mucin MUC1 is a component [120-123]). In mice
and rats, Muc1 is downregulated precisely at the time of
implantation under the control of maternal steroids
[124]. Consistent with this, it emerges as a highly upregu-
lated (6-fold) gene at day 4 in pregnant mice that have
been treated at day 3 with a single dose of RU486 [93].
There is evidence that another surface mucin, Muc4, is
also downregulated in rats [125]. Loss of Muc1 also occurs
in pig and sheep [126,127], while in contrast, humans
express high levels throughout the receptive phase,
though the pattern of its glycosylation changes [120,123].
Indeed, mucin-associated oligosaccharides are useful
markers of endometrial differentiation [123] and pathol-
ogy [128,129].
Experimental studies of human implantation in which
embryos hatch and attach to endometrial epithelial cells
in monolayer culture have shown that Muc1 disappears
from a small area of cells that surround the attached
embryo [130,131]. The mechanism of removal is notReproductive Biology and Endocrinology 2004, 2:48 http://www.rbej.com/content/2/1/48
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established, though it has been shown that a proteolytic
cleavage event catalysed by ADAM17/TACE can mediate
release from the surface of cultured cells, and that
ADAM17 is expressed in the LE [132].
Local remodelling of the glycocalyx implies an earlier
interaction (apposition) that positions the hatched blast-
ocyst at an area of LE where implantation will subse-
quently take place. Carbohydrate-lectin binding has been
suggested to mediate initial weak attachment in a parallel
with the leukocyte-endothelial interaction that occurs at
inflammatory sites [115,133,134]. The epithelial H-type-
1 antigen Fucα1-2Galβ1-3GlcNAcβ1-4 is expressed in LE
in several species [133,134]. Its involvement in implanta-
tion has been suggested in the mouse, where attachment
to endometrial epithelial cells is inhibited by free oli-
gosaccharide in vitro (reviewed in [116]. However, other
evidence suggests that H-type-1 interaction is not essential
to implantation or can be compensated in its absence:
implantation is normal in mice carrying a deletion of
Fut2, the fucosyltransferase required for H-type1 biosyn-
thesis [135]. Furthermore uterine injection of antibody to
H-type-1 fails to block implantation [136]. From anti-
body inhibition in vivo, the possible involvement of the
Le-y carbohydrate antigen (Fucα1-2Galβ1-4[Fucα1-
3]GlcNAcβ1-) was suggested [136,137]. This is present on
the blastocyst surface in mouse and on LE in mouse and
human [138,139]. Since Le-y glycolipid has been demon-
strated to bind H-type-1 and-2 chain glycolipids, Le-y on
the blastocyst could interact with H-type-1 on apical LE
[140]. However, the Fut2 enzyme is again required to pro-
duce ligand.
The selectin ligand sialyl Le-x is present on human LE
where it is carried by MUC-1 [98]. It increases in the
mouse LE during the receptive period [141]. There is
uncertainty as to the expression of selectins on human
and mouse preimplantation embryos [142-144]. In
sheep, the mucin GlyCAM-1, a ligand for L-selectin in
lymph node endothelium, is expressed both by LE and
trophectoderm during the initial interaction period [145].
In homozygotic mutant mice null for each of the three
selectins, and in mice lacking two or all three selectins,
embryonic development, implantation and pregnancy
appear normal [146-148].
Heparan sulphate has been implicated in several implan-
tation models. The blastocyst expresses syndecan-1, a
transmembrane heparan sulphate proteoglycan (HSPG),
but little can be detected at the outer surface of TE [148]
and its absence after gene deletion does not appear to
influence fertility [150]. Perlecan, the major basement
membrane HSPG, surrounds the blastocyst after hatching
and expression of the mRNA and protein correlates with
acquisition of attachment competence [151,152]. Again,
perlecan-null embryos show no implantation phenotype,
being indistinguishable from wild type embryos until
d9.5 [153]. A truncated form of heparin-binding EGF-like
growth factor (HB-EGF) is induced in the LE by the
embryo and could also interact with HSPG [154]. HB-EGF
appears in epithelial cells immediately adjacent to the
implanting embryo just 6–7 hours before the embryo
attaches. In delayed implantation, HB-EGF appears only
after the nidatory E stimulus is given. HB-EGF has been
suggested to play two different roles: in addition to accel-
erating embryo development, it has a membrane-bound
variant that can mediate intercellular attachment by bind-
ing to erb-B4 as well as to heparan sulphate proteoglycan
on the mouse blastocyst [155,156]. HB-EGF-null and erb-
B4-null mice develop heart problems [157,158]. Erb B4
nulls die early in gestation while the majority of HB-EGF
nulls die before weaning. However, surviving HB-EGF-/-
adult females are fertile, and fertile erb-B4 nulls can be
produced after cardiomyocyte-specific rescue of the heart
defect.
Epithelial adhesion molecules
Trophinin is a membrane glycoprotein that forms com-
plexes with the proteins bystin and tastin, and was identi-
fied as a candidate mediator of embryonic attachment by
the demonstration of its involvement in adhesion of
human trophoblastic and endometrial cell lines
[159,160]. Early secretory phase human endometrial epi-
thelium expresses trophinin and tastin at the apical sur-
face, and at the macaque implantation site, trophinin
expression is observed at the apposed apical surfaces of TE
and LE. However, murine implanting blastocysts do not
show detectable levels of trophinin protein, and although
there is a partial embryonic lethality associated with abla-
tion of the gene, this appears to be a post-implantation
phenomenon [161].
Basigin (EMMPRIN, CD147) is an immunoglobulin
superfamily member with putative roles in cell interac-
tion, MMP activation and orientation of ion transporters
in the plasma membrane. It is expressed in the LE [162]
and also in decidual cells [163]. Igakura et al [164]
showed that transfer of wild type blastocysts into basigin-
null females resulted in a very low rate of implantation.
Menstrual cycle-dependent molecular variants have been
observed in human endometrium [165].
Integrin  αvβ3 has been suggested to be important in
embryo attachment in human, mouse, rabbit and farm
animals [5,18]. The β3 subunit exhibits regulated expres-
sion with the heterodimer αvβ3 present in human epithe-
lium only from about day 19. αvβ3 is also present on the
external surface of the expanded blastocyst [142,166]. Its
ligands include fibronectin, vitronectin, tenascin, oste-
opontin, thrombospondin and possibly laminin (seeReproductive Biology and Endocrinology 2004, 2:48 http://www.rbej.com/content/2/1/48
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Diagrammatic representation of the series of interactions between the trophectoderm/trophoblast (TE) and luminal epithelium  (LE) and subjacent stroma Figure 1
Diagrammatic representation of the series of interactions between the trophectoderm/trophoblast (TE) and 
luminal epithelium (LE) and subjacent stroma. Potential roles of cell adhesion molecules at each stage are indicated. 1) 
Pre-receptive polarised endometrial epithelium with desmosomes distributed along lateral LE cell surfaces and non-adhesive 
apical cell surface; 2) Receptive endometrium and initial embryo attachment: reorganisation of lateral LE adhesion complexes 
accompanies apical carbohydrate ligand engagement to tether blastocyst; integrins and cell–bound HB-EGF now become avail-
able for TE-binding; 3) Stabilisation of initial attachment by αv or other integrin-mediated adhesion involving bridging ligands 
shown; other components are also probably functional; 4) Potential signalling through cell adhesion ligand-receptor interaction 
including calmodulin and calcium.Reproductive Biology and Endocrinology 2004, 2:48 http://www.rbej.com/content/2/1/48
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[98,134]). Neutralising antibodies to either αv or β3
integrin injected into mouse uterus, although producing
some apparent effect, failed to induce a statistically signif-
icant reduction in implantation sites. However echistatin,
which inactivates αvβ3 integrin as well as αiibβ3 and
α5β1 [167], and an RGD-containing peptide, did produce
a significant reduction in implantation sites [168]. This
may suggest that other integrins which bind to the RGD
sites in ligands play a redundant or overlapping role in
implantation.
Osteopontin is a secretory product of endometrial glands,
is associated with the apical surface of luminal epithelial
cells, and is directly regulated by P, with maximal abun-
dance in secretory phase [80,169]. Osteopontin can bind
CD44 (which is present on LE [170] as well as several
integrins (αvβ5, αvβ1, α4β1, α5β1 and α8β1). Mice with
ablated CD44, which is also a receptor for hyaluronan, do
not show obviously impaired fertility [171]. Osteopontin
is strongly detected at the apical surface of human
endometrial secretory phase glands [169]. It could act as a
bridging ligand for TE-LE interactions, but osteopontin-
null and osteopontin/vitronectin double knockout mice
are fertile [172].
The largest subfamily of integrins shares the β1 subunit.
This has been localised, along with α1, α2, α3, α4, α5, α6
and α9 to the lateral and basal surfaces, but not the apical
surface, of endometrial epithelial cells (reviewed in
[99,134]). Pregnancy fails in mice lacking integrin β1 at a
stage that closely follows epithelial attachment, perhaps
reflecting a defect in interaction with the stromal ECM
[53]. Expression of integrin α4β1 is highest in human GE
between mid proliferative and mid secretory phases. In
mouse, in addition to its presence on the surface of acti-
vated blastocysts, α4β1 is expressed on the basal LE sur-
face and stromal cells in response to E. Intrauterine
injection of monoclonal antibody to α4 reduced implan-
tation rates substantially though it is not clear what inter-
action was targeted [50].
Conclusions
Since implantation is unique to mammals we cannot
extrapolate from other common model organisms in the
search for possible targets and mechanisms. Nonetheless
our understanding of the process of implantation has
grown slowly in the last decade. Some of the interactions
that have been recognised as important are shown sche-
matically in the Figure. Current in vitro models reproduce
only small stages in the implantation process. Knockout
strategies have revealed the essential role of certain solu-
ble mediators (e.g. LIF) and the contribution to reproduc-
tive efficiency made by others (e.g. GM-CSF), but it is
notable that the crucial structural or attachment mole-
cules have not been identified. The importance of implan-
tation to the survival of mammals means that there may
exist multiple parallel mechanisms. Thus either compen-
satory effects may be invoked or impairment of reproduc-
tive efficiency (rather than system failure) following gene
ablation. Microarray technology has begun to be used in
the search for key implantation mechanisms, but differen-
tial screening approaches will identify only transcription-
ally-regulated products, with post-transcriptionally- and
post-translationally-controlled components likely to
remain undiscovered through current research strategies.
Proteomics may offer a useful complement to existing
approaches.
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